Prognostic Urinary miRNAs for the Assessment of Small Renal Masses.

CONCLUSIONS: Our in-depth miRNA profiling approach identified novel biomarkers for early-stage ccRCC-SRMs. Pretreatment characterization of urinary miRNAs may provide insight into early RCC progression and could potentially aid clinical decision-making, improving patient management and reducing overtreatment.
PMID: 31672647 [PubMed - as supplied by publisher]

Source: Clinical Biochemistry - October 27, 2019 Category: Biochemistry Authors: Di Meo A, Brown MD, Finelli A, Jewett MAS, Diamandis EP, Yousef GM Tags: Clin Biochem Source Type: research